The global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) [ 7 ], resulting from the coexistence of metabolic syndrome and/or NAFLD, continues to show an increasing trend [ 8 ].
← all excerpts
Effect of treadmill walking on cardiometabolic risk factors and liver function markers in older adults with MASLD: a randomized controlled trial.
1
—
—